Unravelling Voriconazole's Hepatic Metabolism: A Narrative Review on Factors Impacting Voriconazole-N-Oxide Exposure. [PDF]
Hubrechts J +9 more
europepmc +1 more source
Genetic variability and response to sertraline in pediatric populations: a review on pharmacogenetics, pharmacokinetics, and the risk of adverse events. [PDF]
Gándara-Mireles JA +7 more
europepmc +1 more source
CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx). [PDF]
Dello Russo C +22 more
europepmc +1 more source
CYP2D6- en CYP2C19-genotypering
Koopmans, A. B. +3 more
openaire +1 more source
Studies Based on CYP2C19 Genotypes
Takahisa FURUTA, Mitsushige SUGIMOTO
openaire +2 more sources
Association Between <i>CYP2C9</i> and <i>CYP2C19</i> Genetic Polymorphisms and Antiseizure Medication-Induced Adverse Reactions Among Peruvian Patients with Epilepsy. [PDF]
Alvarado AT +18 more
europepmc +1 more source
PBPK modeling of the antidepressant doxepin incorporating CYP2D6 genotype for precision pharmacotherapy. [PDF]
Seok J, Kang N, Lee JJ, Cho CK, Lee YJ.
europepmc +1 more source
Optimization strategies for voriconazole dosing in pediatric populations: integrating therapeutic indications and age-stratified pharmacokinetics. [PDF]
Zhu Y +12 more
europepmc +1 more source
Impact of CYP2C19 point-of-care testing on the clinical outcome in patients receiving personalized clopidogrel therapy: systemic review and meta-analysis. [PDF]
Mohammed S +8 more
europepmc +1 more source

